Ur Metser

8.5k total citations · 1 hit paper
220 papers, 5.6k citations indexed

About

Ur Metser is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ur Metser has authored 220 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pulmonary and Respiratory Medicine, 110 papers in Radiology, Nuclear Medicine and Imaging and 55 papers in Oncology. Recurrent topics in Ur Metser's work include Radiomics and Machine Learning in Medical Imaging (51 papers), Medical Imaging Techniques and Applications (48 papers) and Prostate Cancer Treatment and Research (42 papers). Ur Metser is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (51 papers), Medical Imaging Techniques and Applications (48 papers) and Prostate Cancer Treatment and Research (42 papers). Ur Metser collaborates with scholars based in Canada, Israel and United States. Ur Metser's co-authors include Einat Even‐Sapir, Hedva Lerman, Gennady Lievshitz, Eyal Mishani, Ilan Leibovitch, Elka Miller, Gideon Flusser, Patrick Veit‐Haibach, Claudia Ortega and Ami Fishman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ur Metser

204 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

2006 589 citations Einat Even‐Sapir, Ur Metser et al. profile →

Peers

Countries citing papers authored by Ur Metser

Since Specialization

Citations

This map shows the geographic impact of Ur Metser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ur Metser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ur Metser more than expected).

Fields of papers citing papers by Ur Metser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ur Metser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ur Metser. The network helps show where Ur Metser may publish in the future.

Co-authorship network of co-authors of Ur Metser

This figure shows the co-authorship network connecting the top 25 collaborators of Ur Metser. A scholar is included among the top collaborators of Ur Metser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ur Metser. Ur Metser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Theranostic: A Primer for Radiologists 2025 ·Canadian Association of Radiologists Journal ·Seyed Ali Mirshahvalad, Mohsen Beheshti, Ur Metser, Di Jiang, Rebecca Wong, (unknown), Patrick Veit‐Haibach	1
2	Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy 2025 ·Scientific Reports ·Seyed Ali Mirshahvalad, Andrés Kohan, (unknown), Claudia Ortega, Ur Metser, David Hodgson, Robert Kridel, Christine Chen, Sita Bhella, Patrick Veit‐Haibach	0
3	Predictive [18F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer 2024 ·Academic Radiology ·Ricarda Hinzpeter, (unknown), Andrés Kohan, (unknown), Seyed Ali Mirshahvalad, Lisa Avery, Claudia Ortega, Ur Metser, Andrew Hope, Jonathan Yeung, Micheal McInnis, Patrick Veit‐Haibach	9
4	Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot Study 2024 ·Academic Radiology ·Seyed Ali Mirshahvalad, Adriano Basso Dias, Sangeet Ghai, Claudia Ortega, Nathan Perlis, Alejandro Berlín, Lisa Avery, Theodorus van der Kwast, Ur Metser, Patrick Veit‐Haibach	0
5	Dual Somatostatin Receptor/¹⁸F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors 2024 ·Journal of Nuclear Medicine ·Ur Metser, Jose E. Nuñez, (unknown), (unknown), (unknown), (unknown), Simron Singh	4
6	A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Irene Karam, (unknown), (unknown), (unknown), (unknown), Eric Berthelet, (unknown), Andrea McNiven, Timothy Fitzgerald, Winson Y. Cheung, (unknown), Ur Metser, E. Yu, L. Gauthier, Khalil Sultanem, (unknown), (unknown), (unknown), Wendy R. Parulekar	3
7	Association of Free-to-Total PSA Ratio and¹⁸F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study 2024 ·Journal of Nuclear Medicine ·Rui Bernardino, Katherine Lajkosz, (unknown), Rashid K. Sayyid, Marian S. Wettstein, Harkanwal Randhawa, (unknown), (unknown), (unknown), Eleftherios P. Diamandis, Ur Metser, Alejandro Berlín, Neil Fleshner	0
8	Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma 2023 ·Cancers ·Claudia Ortega, Yael Eshet, Anca Prica, Reut Anconina, Sarah Johnson, (unknown), Sareh Keshavarzi, (unknown), Ur Metser, Patrick Veit‐Haibach	14
9	18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas 2023 ·Langenbeck s Archives of Surgery ·(unknown), Lorne Rotstein, Antoine Eskander, (unknown), (unknown), Adrienne H. Brouwers, Schelto Kruijff, Ur Metser, (unknown), (unknown)	9
10	Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial 2023 ·Cancer Imaging ·Samuel Tremblay, (unknown), Andrew Weickhardt, Ian D. Davis, Andrew M. Scott, Rodney J. Hicks, Ur Metser, Sue Chua, (unknown), Shonit Punwani, Heather Payne, Nina Tunariu, Bao Ho, (unknown), (unknown), Glenn Bauman, Louise Emmett, Frédéric Pouliot	1
11	Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer 2023 ·British Journal of Urology ·Rashid K. Sayyid, Rui Bernardino, (unknown), (unknown), (unknown), (unknown), Ricardo Leão, (unknown), (unknown), Ur Metser, Alejandro Berlín, Neil Fleshner	0
12	Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies 2023 ·Clinical Nuclear Medicine ·Adriano Basso Dias, Sangeet Ghai, Claudia Ortega, Seyed Ali Mirshahvalad, Nathan Perlis, Alejandro Berlín, Lisa Avery, Patrick Veit‐Haibach, Theodorus van der Kwast, Ur Metser	5
13	A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer 2022 ·Clinical Cancer Research ·Kathy Han, Anthony Fyles, (unknown), Jennifer Croke, Neesha C. Dhani, David D’Souza, Ting‐Yim Lee, Naz Chaudary, Jeffrey P. Bruce, Melania Pintilie, Rob A. Cairns, Douglass Vines, Sara Pakbaz, David A. Jaffray, Ur Metser, Marjan Rouzbahman, Michael Milosevic, Marianne Koritzinsky	20
14	Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up 2022 ·Cancers ·Adam A. Dmytriw, Claudia Ortega, Reut Anconina, Ur Metser, (unknown), (unknown), Xuan Li, (unknown), Eugene Yu, (unknown), John Waldron, Shao Hui Huang, Scott V. Bratman, Andrew Hope, Patrick Veit‐Haibach	5
15	Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis 2022 ·Radiology ·(unknown), Michael Chan, (unknown), Ashley Farrell, Nayaar Islam, Matthew D. F. McInnes, (unknown), Meyer Balter, Yasbanoo Moayedi, Paaladinesh Thavendiranathan, Ur Metser, Patrick Veit‐Haibach, Kate Hanneman	52
16	Impact of ¹⁸F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer 2022 ·Radiology ·Adriano Basso Dias, Antonio Finelli, Glenn Bauman, Patrick Veit‐Haibach, Alejandro Berlín, Claudia Ortega, Lisa Avery, Ur Metser	15
17	Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer 2021 ·Canadian Urological Association Journal ·(unknown), Katherine Zukotynski, François Bénard, Cynthia Ménard, (unknown), Glenn Bauman, Patrick Veit‐Haibach, Ur Metser	13
18	[ ¹⁸ F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial 2020 ·BMJ Open ·Rachel Glicksman, Ur Metser, John F. Valliant, Peter Chung, Neil Fleshner, Robert G. Bristow, David Green, Antonio Finelli, Robert J. Hamilton, (unknown), Douglas Hussey, Charles Catton, Mary Gospodarowicz, Padraig Warde, Andrew Bayley, Stephen Breen, (unknown), David A. Jaffray, Alejandro Berlín	6
19	Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer 2018 ·Clinical Cancer Research ·Jennifer Haynes, Trevor D. McKee, (unknown), Yadong Wang, Cherry Leung, Deena M.A. Gendoo, Evelyne Lima‐Fernandes, Antonija Kreso, (unknown), Eva Szentgyörgyi, Douglass Vines, Benjamin Haibe‐Kains, Bradly G. Wouters, Ur Metser, David A. Jaffray, (unknown), Catherine O′Brien	17
20	18F-FDG PET/CT in the Evaluation of Adrenal Masses 2015 ·Ur Metser, Elka Miller, Hedva Lerman, Gennady Lievshitz, Shmuel Avital, Einat Even‐Sapir	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact